Bonini Matteo
National Heart and Lung Institute (NHLI), Imperial College London & Royal Brompton Hospital, London, UK.
Curr Opin Pulm Med. 2017 Jan;23(1):21-26. doi: 10.1097/MCP.0000000000000336.
Asthma is the most prevalent chronic respiratory disease and represents a relevant socioeconomic burden. e-Health has the potential to improve disease control and adherence to treatment in asthmatic patients. Available data are, however, scarce and inconsistent limiting the use of e-health in clinical practice. This article aims to provide a systematic review of the literature published in the last year regarding the real place and impact of e-health in the management of asthma.
Despite few conflicting results, collected findings support a beneficial effect of e-health on asthma management and control, as well as positive patients' acceptance and satisfaction. Included studies mainly assessed m-health, telemedicine, electronic health record and digital app interventions, in both adults and children. Existing evidence appears however to be only of moderate quality and high heterogeneity was found in the study endpoints and designs.
There is the need to establish widely adopted standards for conducting trials and reporting results in e-health. These should include minimal clinical difference assessment and prevent potential pitfalls such as patient privacy protection, data fishing and lack of compliance of interventions with evidence-based medicine, guideline recommendations and regulatory board statements.
哮喘是最常见的慢性呼吸道疾病,也是一个重大的社会经济负担。电子健康有潜力改善哮喘患者的疾病控制和治疗依从性。然而,现有数据稀少且不一致,限制了电子健康在临床实践中的应用。本文旨在对去年发表的关于电子健康在哮喘管理中的实际地位和影响的文献进行系统综述。
尽管有一些相互矛盾的结果,但汇总的研究结果支持电子健康对哮喘管理和控制有有益作用,以及患者有积极的接受度和满意度。纳入的研究主要评估了成人和儿童的移动健康、远程医疗、电子健康记录和数字应用干预。然而,现有证据质量似乎仅为中等,且在研究终点和设计方面发现了高度异质性。
需要建立广泛采用的电子健康试验标准和结果报告标准。这些标准应包括最小临床差异评估,并防止潜在的陷阱,如患者隐私保护、数据挖掘以及干预措施不符合循证医学、指南建议和监管委员会声明。